Back to search
Scientific Name: Trametinib
Brand Name: Mekinist
Company Owner: Not Available
Mechanism Of Action Trametinib is a reversible, allosteric inhibitor of mitogen-activated extracellular signal regulated kinase 1
Description of the Drug: Trametinib is a kinase inhibitor used to treat patients with specific types of melanoma, non-small cell lung cancer, and thyroid cancer.
Protein Data Bank:
Source: DrugBank Online – Retrieved 2023-01-23 from